Bailon, P <br/><br/>
Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis C.  [electronic resource] 

 -  Bioconjugate chemistry   
 - 195-202 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1043-1802 
<br/><br/><label>Standard No.: </label>10.1021/bc000082g  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--chemical synthesis<br/>Antiviral Agents--chemical synthesis<br/>Cell Line<br/>Clinical Trials, Phase II as Topic<br/>Clinical Trials, Phase III as Topic<br/>Drug Design<br/>Drug Screening Assays, Antitumor<br/>Female<br/>Hepatitis C--drug therapy<br/>Humans<br/>Immunoblotting<br/>Interferon alpha-2<br/>Interferon-alpha--chemical synthesis<br/>Mice<br/>Mice, Nude<br/>Molecular Structure<br/>Neoplasms--drug therapy<br/>Polyethylene Glycols--chemical synthesis<br/>Rats<br/>Rats, Sprague-Dawley<br/>Recombinant Proteins<br/>Vesicular stomatitis Indiana virus--drug effects